Dinja Oosterhoff

998 total citations
30 papers, 808 citations indexed

About

Dinja Oosterhoff is a scholar working on Immunology, Oncology and Genetics. According to data from OpenAlex, Dinja Oosterhoff has authored 30 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 14 papers in Oncology and 9 papers in Genetics. Recurrent topics in Dinja Oosterhoff's work include Immunotherapy and Immune Responses (16 papers), Virus-based gene therapy research (9 papers) and CAR-T cell therapy research (8 papers). Dinja Oosterhoff is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), Virus-based gene therapy research (9 papers) and CAR-T cell therapy research (8 papers). Dinja Oosterhoff collaborates with scholars based in Netherlands, United States and Germany. Dinja Oosterhoff's co-authors include Tanja D. de Gruijl, Rik J. Scheper, Alfons J.M. van den Eertwegh, Jelle J. Lindenberg, Victor W. van Beusechem, Rieneke van de Ven, Elly van Riet, Sinéad M. Lougheed, Hester van Cruijsen and P.A. van der Ley and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Cancer Research.

In The Last Decade

Dinja Oosterhoff

30 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dinja Oosterhoff Netherlands	19	445	325	280	123	67	30	808
Hansjörg Schild Germany	13	805 1.8×	179 0.6×	356 1.3×	74 0.6×	63 0.9×	13	1.0k
Thi-Sau Migone United States	8	736 1.7×	411 1.3×	265 0.9×	90 0.7×	77 1.1×	8	1.1k
Melissa de los Reyes United States	9	480 1.1×	173 0.5×	272 1.0×	56 0.5×	117 1.7×	16	908
Davor Frleta United States	12	491 1.1×	227 0.7×	234 0.8×	59 0.5×	74 1.1×	18	847
Rachel Lubong Sabado United States	14	1.1k 2.5×	517 1.6×	435 1.6×	56 0.5×	71 1.1×	37	1.4k
Dariusz Kowalczyk Poland	15	330 0.7×	324 1.0×	441 1.6×	234 1.9×	54 0.8×	41	953
Warren McComas United States	8	690 1.6×	233 0.7×	286 1.0×	147 1.2×	63 0.9×	11	1.1k
María Martínez‐López Spain	11	893 2.0×	364 1.1×	243 0.9×	50 0.4×	67 1.0×	13	1.1k
Steven L. Giardina United States	14	372 0.8×	181 0.6×	367 1.3×	100 0.8×	43 0.6×	16	810
Brigitte Lemercier France	16	481 1.1×	202 0.6×	276 1.0×	116 0.9×	151 2.3×	21	952

Countries citing papers authored by Dinja Oosterhoff

Since Specialization

Citations

This map shows the geographic impact of Dinja Oosterhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dinja Oosterhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dinja Oosterhoff more than expected).

Fields of papers citing papers by Dinja Oosterhoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dinja Oosterhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dinja Oosterhoff. The network helps show where Dinja Oosterhoff may publish in the future.

Co-authorship network of co-authors of Dinja Oosterhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Dinja Oosterhoff. A scholar is included among the top collaborators of Dinja Oosterhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dinja Oosterhoff. Dinja Oosterhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ley, P.A. van der, et al.. (2021). An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection. Frontiers in Immunology. 12. 87 indexed citations

Hirschberg, Hoang, Elly van Riet, Dinja Oosterhoff, Joke A. Bouwstra, & Gideon Kersten. (2015). Animal models for cutaneous vaccine delivery. European Journal of Pharmaceutical Sciences. 71. 112–122. 16 indexed citations

Lindenberg, Jelle J., Rieneke van de Ven, Dinja Oosterhoff, et al.. (2014). Induction of dendritic cell maturation in the skin microenvironment by soluble factors derived from colon carcinoma. Human Vaccines & Immunotherapeutics. 10(6). 1622–1632. 4 indexed citations

Ven, Rieneke van de, Jelle J. Lindenberg, Dinja Oosterhoff, & Tanja D. de Gruijl. (2013). Dendritic Cell Plasticity in Tumor-Conditioned Skin: CD14+ Cells at the Cross-Roads of Immune Activation and Suppression. Frontiers in Immunology. 4. 403–403. 35 indexed citations

Lindenberg, Jelle J., Dinja Oosterhoff, Claudia C. Sombroek, et al.. (2013). IL-10 Conditioning of Human Skin Affects the Distribution of Migratory Dendritic Cell Subsets and Functional T Cell Differentiation. PLoS ONE. 8(7). e70237–e70237. 29 indexed citations

Lindenberg, Jelle J., Rieneke van de Ven, Sinéad M. Lougheed, et al.. (2013). Functional characterization of a STAT3-dependent dendritic cell-derived CD14⁺cell population arising upon IL-10-driven maturation. OncoImmunology. 2(4). e23837–e23837. 30 indexed citations

Oosterhoff, Dinja, Sinéad M. Lougheed, Rieneke van de Ven, et al.. (2012). Tumor-mediated inhibition of human dendritic cell differentiation and function is consistently counteracted by combined p38 MAPK and STAT3 inhibition. OncoImmunology. 1(5). 649–658. 50 indexed citations

Large, Tessa Y. S. Le, Nicolas Tarbouriech, Dinja Oosterhoff, et al.. (2012). Epstein-Barr Virus-Encoded BARF1 Protein is a Decoy Receptor for Macrophage Colony Stimulating Factor and Interferes with Macrophage Differentiation and Activation. Viral Immunology. 25(6). 461–470. 23 indexed citations

Hangalapura, Basav N., Dinja Oosterhoff, Jan de Groot, et al.. (2011). Potent Antitumor Immunity Generated by a CD40-Targeted Adenoviral Vaccine. Cancer Research. 71(17). 5827–5837. 26 indexed citations

10.

Hangalapura, Basav N., Dinja Oosterhoff, Tarun Gupta, et al.. (2011). Delivery route, MyD88 signaling and cross-priming events determine the anti-tumor efficacy of an adenovirus based melanoma vaccine. Vaccine. 29(12). 2313–2321. 18 indexed citations

11.

Oosterhoff, Dinja, Berbel J.R. Sluijter, Basav N. Hangalapura, & Tanja D. de Gruijl. (2011). The Dermis as a Portal for Dendritic Cell-Targeted Immunotherapy of Cutaneous Melanoma. Current topics in microbiology and immunology. 351. 181–220. 14 indexed citations

12.

Hangalapura, Basav N., Dinja Oosterhoff, Pepijn G.J.T.B. Wijnands, et al.. (2010). Selective Transduction of Dendritic Cells in Human Lymph Nodes and Superior Induction of High-avidity Melanoma-reactive Cytotoxic T Cells by a CD40-targeted Adenovirus. Journal of Immunotherapy. 33(7). 706–715. 21 indexed citations

13.

Ven, Rieneke van de, Jelle J. Lindenberg, Dinja Oosterhoff, et al.. (2009). Selective Transduction of Mature DC in Human Skin and Lymph Nodes by CD80/CD86-targeted Fiber-modified Adenovirus-5/3. Journal of Immunotherapy. 32(9). 895–906. 9 indexed citations

14.

Cruijsen, Hester van, Astrid A.M. van der Veldt, Dinja Oosterhoff, et al.. (2008). Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c+ Dendritic Cell Frequency Predicts Progression-Free Survival. Clinical Cancer Research. 14(18). 5884–5892. 111 indexed citations

15.

Gruijl, Tanja D. de, Claudia C. Sombroek, Sinéad M. Lougheed, et al.. (2006). A Postmigrational Switch among Skin-Derived Dendritic Cells to a Macrophage-Like Phenotype Is Predetermined by the Intracutaneous Cytokine Balance. The Journal of Immunology. 176(12). 7232–7242. 56 indexed citations

16.

Oosterhoff, Dinja, H. M. Pinedo, M.A. Witlox, et al.. (2005). Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdΔ24. Gene Therapy. 12(12). 1011–1018. 19 indexed citations

17.

Oosterhoff, Dinja, Marlies de Graaf, Giuseppe Giaccone, et al.. (2005). Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11. British Journal of Cancer. 92(5). 882–887. 22 indexed citations

18.

Pinedo, Herbert M., Dinja Oosterhoff, Ida H. van der Meulen‐Muileman, et al.. (2004). Pronounced Antitumor Efficacy by Extracellular Activation of a Doxorubicin-Glucuronide Prodrug After Adenoviral Vector-Mediated Expression of a Human Antibody-Enzyme Fusion Protein. Human Gene Therapy. 15(3). 229–238. 13 indexed citations

19.

Graaf, Marlies de, Epie Boven, Dinja Oosterhoff, et al.. (2002). A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug. British Journal of Cancer. 86(5). 811–818. 27 indexed citations

20.

Oosterhoff, Dinja, Herbert M. Pinedo, Marlies de Graaf, et al.. (2002). Secreted and tumour targeted human carboxylesterase for activation of irinotecan. British Journal of Cancer. 87(6). 659–664. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact